Light After Armageddon: Enhancing Cardiovascular Care through Emerging Technologies and Patient-Centric Approaches.

Author(s)
Gruson, Damien
Peranio, Chiara
Bernardini, Sergio
Štaraitė, Aistė
Koo, Mikki
Coyle, Mike
Shannon, Bryan
Luu, David
Harding, Ed
Kemaloğlu Öz, Tuğba
Publication Date
2024-12-30
Abstract
No abstract available
Affiliation
Department of Laboratory Medicine, Cliniques Universitaires St-Lux, Brussels, Belgium and Université Catholique de Louvain, Brussels, Belgium.
Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc and Université Catholique de Louvain, Brussels, Belgium.
IFCC Division on Emerging Technologies.
Communication and digital Marketing, University Mercatorum, Roma, Italy.
Department. of Experimental Medicine, University of Tor Vergata, Roma, Italy.
Global Heart Hub, The International Alliance of Heart Patient Organisations.
Roche Diagnostics International, Switzerland.
Roche Diagnostics International, Switzerland.
ParadigmDx, Carlsbad, California, USA.
The Heart Fund, Paris, France.
Health Policy Partnership, London, United Kingdom.
Alice Springs Hospital, Alice Springs, Australia.
Flinders University, Faculty of Medicine, SA, Australia.
Citation
EJIFCC . 2024 Dec 30;35(4):212-215. eCollection 2024 Dec.
ISSN
1650-3414
Pubmed ID
https://pubmed.ncbi.nlm.nih.gov/39810894/?otool=iaurydwlib
Link
Subject
Cardiovascular diseases
artificial intelligence
biomarkers
emerging technologies
prevention
Title
Light After Armageddon: Enhancing Cardiovascular Care through Emerging Technologies and Patient-Centric Approaches.
Type of document
Journal Article
Entity Type
Publication

Files:

NameSizeformatDescriptionLink
https://digitallibrary.health.nt.gov.au/nthealthserver/api/core/items/c4a8bef3-1cf5-4170-b8f1-c8b5a8c48c2a